药学研究平台
Pharmaceutical Research Platform
药物安全评价研究中心
Center for Drug Safety Evaluation and Research
临床医学平台
Clinical Medicine Platform
生物技术平台
Biotechnology Platform
美莱德已成熟构建药学研究、药物安全评价研究中心、临床医学、生物技术四大综合性平台，涉及药品研发领域各板块， 旨在通过高效率的研发服务缩短药物研发周期、降低研发成本，为制药研发机构和企业提供从GLP到GCP的全链条CRO服务。
With the state-of-the-art facilities and strong expertise in advanced technologies, we have successfully set up four comprehensive platforms including Pharmaceutical Research, Center for Drug Safety Evaluation and Research, Clinical Medicine and Biotechnology. Involved in various phases of drug research and development, Medleader dedicates to shorten the cycle of drug R&D and reduce the cost of research and development through efficient research and development services, and to provide the whole-chain CRO service from GLP to GCP for pharmaceutical research and development institutions and enterprises.
新闻动态
News
theme : {{item.enTitle}}
Time : {{item.activityTime}}
address : {{item.enAddress}}
{{item.enIntro}}
关于我们
About Us
重庆美莱德生物医药有限公司成立于2017年初，是一家综合性的生物医药研发服务公司(CRO), 主要致力于化学药、预防用及治疗用生物制品及医疗器械的临床前研究和临床研究服务。 公司已成熟构建药学研究、药物安全评价研究中心、临床医学、生物技术四大综合性平台，涉及药品研发领域各板块，旨在通过高效率的研发服务缩短药物研发周期、降低研发成本，为制药研发机构和企业提供从GLP到GCP的全链条CRO服务。 公司将技术创新和科学规范的项目管理作为立身之本和发展之源，重视研发管理和人才积累，以国际、国内的高端科研人才为主组建了研发人才梯队。公司拥有药学、医学、化学、生物学、统计学等各生物医药相关专业优秀人才，同时也拥有经验丰富的核心管理团队，人才队伍结构稳定，组织结构完善。
Founded in 2017, Chongqing Medleader Bio-Pharm Co., Ltd. is a comprehensive Contract Research Organization focused on pre-clinical and clinical research services regarding chemical drugs, preventive and therapeutic biological products and medical devices.
Focusing on R&D management and having established a R&D team with international and domestic high-end scientific personnel, Medleader regards technological innovation and standardized project management as the foundation and source of development. We own the professional team with pharmaceutical, medical, chemistry, biology, and statistics backgrounds and the core management team experienced in biomedical industry.